ImmunediveRsity statistics

info info

Citations per year

info

Popular tool citations

chevron_left Bioinformatics workflows chevron_right
info

Tool usage distribution map

Tool usage distribution map
info info

Associated diseases

Associated diseases
Want to access the full stats & trends on this tool?

Protocols

ImmunediveRsity specifications

Information


Unique identifier OMICS_08094
Name ImmunediveRsity
Software type Package/Module
Interface Command line interface
Restrictions to use None
Input data RepSeq library raw reads
Output data Analysis results
Biological technology Illumina, Roche
Operating system Unix/Linux, Mac OS, Windows
Programming languages R
License GNU General Public License version 2.0
Computer skills Advanced
Version 1.0.8
Stability Stable
Requirements
Python, C
Maintained Yes

Versioning


No version available

Documentation


Publication for ImmunediveRsity

ImmunediveRsity citations

 (2)
library_books

Lower IgG somatic hypermutation rates during acute dengue virus infection is compatible with a germinal center independent B cell response

2016
Genome Med
PMCID: 4766701
PMID: 26917418
DOI: 10.1186/s13073-016-0276-1

[…] central value of 1200 au (12-fold increase relative to an mb cell), a minimal value of 300, and a maximal value of 10,000 au [] (additional file )., we have developed a software (pipeline) named immunediversity for the analysis of the repertoire sequencing (rep-seq) data []. immunediversity is written in r language [] and automates ig sequencing analysis from pre-processing, error correction […]

library_books

Longitudinal analysis of the peripheral B cell repertoire reveals unique effects of immunization with a new influenza virus strain

2015
Genome Med
PMCID: 4658769
PMID: 26608341
DOI: 10.1186/s13073-015-0239-y

[…] igg vh amplicons derived from peripheral blood rna from pre-immune and 7 days post vaccination were subjected to 454-roche sequencing. full reconstruction of the sampled repertoires was done with immunediversity., the tiv induced a predominantly homotypic neutralizing serologic response, while the 09 miv induced a heterotypic neutralizing seroconversion in 17 % of the individuals. […]


Want to access the full list of citations?
ImmunediveRsity institution(s)
Department of Immunology, Research Center for Infectious Diseases at the National Institute of Public Health (INSP-CISEI), Cuernavaca, Morelos, Mexico

ImmunediveRsity reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review ImmunediveRsity